Literature DB >> 29703996

Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats.

Brooke E Schmeichel1,2, Alessandra Matzeu3, Pascale Koebel4, Leandro F Vendruscolo5, Harpreet Sidhu3, Roxana Shahryari3, Brigitte L Kieffer4,6, George F Koob5, Rémi Martin-Fardon3, Candice Contet3.   

Abstract

The hypocretin/orexin (HCRT) neuropeptide system regulates feeding, arousal state, stress responses, and reward, especially under conditions of enhanced motivational relevance. In particular, HCRT neurotransmission facilitates drug-seeking behavior in circumstances that demand increased effort and/or motivation to take the drug. The present study used a shRNA-encoding adeno-associated viral vector to knockdown Hcrt expression throughout the dorsal hypothalamus in adult rats and determine the role of HCRT in cocaine self-administration. Chronic Hcrt silencing did not impact cocaine self-administration under short-access conditions, but robustly attenuated cocaine intake under extended access conditions, a model that mimics key features of compulsive cocaine taking. In addition, Hcrt silencing decreased motivation for both cocaine and a highly palatable food reward (i.e., sweetened condensed milk; SCM) under a progressive ratio schedule of reinforcement, but did not alter responding for SCM under a fixed ratio schedule. Importantly, Hcrt silencing did not affect food or water consumption, and had no consequence for general measures of arousal and stress reactivity. At the molecular level, chronic Hcrt knockdown reduced the number of neurons expressing dynorphin (DYN), and to a smaller extent melanin-concentrating hormone (MCH), in the dorsal hypothalamus. These original findings support the hypothesis that HCRT neurotransmission promotes operant responding for both drug and non-drug rewards, preferentially under conditions requiring a high degree of motivation. Furthermore, the current study provides compelling evidence for the involvement of the HCRT system in cocaine self-administration also under low-effort conditions in rats allowed extended access, possibly via functional interactions with DYN and MCH signaling.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29703996      PMCID: PMC6180106          DOI: 10.1038/s41386-018-0054-4

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  97 in total

1.  Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access.

Authors:  Sunmee Wee; Chitra D Mandyam; Dusan M Lekic; George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-24       Impact factor: 4.600

2.  Suppression of alcohol self-administration and reinstatement of alcohol seeking by melanin-concentrating hormone receptor 1 (MCH1-R) antagonism in Wistar rats.

Authors:  Andrea Cippitelli; Camilla Karlsson; Janice L Shaw; Annika Thorsell; Donald R Gehlert; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2010-07-14       Impact factor: 4.530

3.  Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior.

Authors:  Ainhoa Plaza-Zabala; Elena Martín-García; Luis de Lecea; Rafael Maldonado; Fernando Berrendero
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

4.  Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

Authors:  J Hara; C T Beuckmann; T Nambu; J T Willie; R M Chemelli; C M Sinton; F Sugiyama; K Yagami; K Goto; M Yanagisawa; T Sakurai
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

5.  Use of vivo-morpholinos for control of protein expression in the adult rat brain.

Authors:  Kathryn J Reissner; Gregory C Sartor; Elena M Vazey; Thomas E Dunn; Gary Aston-Jones; Peter W Kalivas
Journal:  J Neurosci Methods       Date:  2011-10-17       Impact factor: 2.390

6.  Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides.

Authors:  Ying Li; Anthony N van den Pol
Journal:  J Neurosci       Date:  2006-12-13       Impact factor: 6.167

7.  Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin.

Authors:  Rodrigo A España; Stacey Plahn; Craig W Berridge
Journal:  Brain Res       Date:  2002-07-12       Impact factor: 3.252

8.  Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats.

Authors:  Robyn Mary Brown; Shaun Yon-Seng Khoo; Andrew John Lawrence
Journal:  Int J Neuropsychopharmacol       Date:  2013-04-22       Impact factor: 5.176

9.  The melanin-concentrating hormone system modulates cocaine reward.

Authors:  Shinjae Chung; F Woodward Hopf; Hiroshi Nagasaki; Chun-Ying Li; James D Belluzzi; Antonello Bonci; Olivier Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-02       Impact factor: 11.205

10.  Compulsive drug seeking by rats under punishment: effects of drug taking history.

Authors:  Yann Pelloux; Barry J Everitt; Anthony Dickinson
Journal:  Psychopharmacology (Berl)       Date:  2007-05-21       Impact factor: 4.530

View more
  16 in total

1.  Sex Differences in Escalated Methamphetamine Self-Administration and Altered Gene Expression Associated With Incubation of Methamphetamine Seeking.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Bruce Ladenheim; Michael T McCoy; Christie Brannock; Jennifer Schroeder; Jean Lud Cadet
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176

Review 2.  Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect.

Authors:  Steven J Simmons; Taylor A Gentile
Journal:  Brain Res       Date:  2019-02-20       Impact factor: 3.252

3.  The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task.

Authors:  Joost Wiskerke; Morgan H James; Gary Aston-Jones
Journal:  Brain Res       Date:  2019-04-16       Impact factor: 3.252

4.  Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine.

Authors:  Caroline B Pantazis; Morgan H James; Shayna O'Connor; Noah Shin; Gary Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2021-10-11       Impact factor: 7.853

5.  Effects of single and dual hypocretin-receptor blockade or knockdown of hypocretin projections to the central amygdala on alcohol drinking in dependent male rats.

Authors:  Gabriel M Aldridge; Tyler A Zarin; Adam J Brandner; Olivier George; Nicholas W Gilpin; Vez Repunte-Canonigo; Pietro P Sanna; George F Koob; Leandro F Vendruscolo; Brooke E Schmeichel
Journal:  Addict Neurosci       Date:  2022-07-03

Review 6.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

7.  Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells.

Authors:  Jiann W Yeoh; Morgan H James; Cameron D Adams; Jaideep S Bains; Takeshi Sakurai; Gary Aston-Jones; Brett A Graham; Christopher V Dayas
Journal:  Neuropharmacology       Date:  2018-09-22       Impact factor: 5.250

8.  Sex- and Brain Region-specific Changes in Gene Expression in Male and Female Rats as Consequences of Methamphetamine Self-administration and Abstinence.

Authors:  Atul P Daiwile; Subramaniam Jayanthi; Jean Lud Cadet
Journal:  Neuroscience       Date:  2020-11-24       Impact factor: 3.590

Review 9.  Orexins, Sleep, and Blood Pressure.

Authors:  Mariusz Sieminski; Jacek Szypenbejl; Eemil Partinen
Journal:  Curr Hypertens Rep       Date:  2018-07-10       Impact factor: 5.369

Review 10.  Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation.

Authors:  Natalie Nevárez; Luis de Lecea
Journal:  F1000Res       Date:  2018-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.